Prosperity Capital Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Buy |
3,526
+417
| +13% | +$28.8K | 0.02% | 252 |
|
|
2025
Q1 | $212K | Sell |
3,109
-14
| -0.4% | -$953 | 0.02% | 338 |
|
|
2024
Q4 | $269K | Buy |
3,123
+202
| +7% | +$17.4K | 0.02% | 297 |
|
|
2024
Q3 | $348K | Buy |
2,921
+41
| +1% | +$4.88K | 0.03% | 254 |
|
|
2024
Q2 | $411K | Sell |
2,880
-476
| -14% | -$67.9K | 0.05% | 215 |
|
|
2024
Q1 | $431K | Buy |
3,356
+844
| +34% | +$108K | 0.05% | 225 |
|
|
2023
Q4 | $260K | Buy |
2,512
+266
| +12% | +$27.5K | 0.03% | 221 |
|
|
2023
Q3 | $204K | Buy |
+2,246
| New | +$204K | 0.03% | 230 |
|